Edition:
United States

Benitec Biopharma Ltd (BNTC.OQ)

BNTC.OQ on NASDAQ Stock Exchange Capital Market

2.86USD
15 Dec 2017
Change (% chg)

$-0.05 (-1.72%)
Prev Close
$2.91
Open
$2.96
Day's High
$2.96
Day's Low
$2.80
Volume
3,240
Avg. Vol
10,521
52-wk High
$5.48
52-wk Low
$1.31

Chart for

About

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Benitec Biopharma Posts Qtrly ‍Loss Of A$2.9 mln

* QTRLY ‍LOSS OF A$2.9 MILLION VERSUS PROFIT OF A$0.8 MILLION​ Source text for Eikon: Further company coverage:

Nov 29 2017

BRIEF-Benitec Biopharma provides update On Opmd Orphan Disease program

* BENITEC BIOPHARMA PROVIDES UPDATE ON OPMD ORPHAN DISEASE PROGRAM

Nov 27 2017

BRIEF-Benitec Biopharma says working with regulators to advance BB-301 into the clinic as quickly as possible

* Benitec Biopharma says its BB-301, represents clinical candidate that it intends to advance into human clinical trials in the second half of 2018‍​

Aug 08 2017

Earnings vs. Estimates